Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study

Background: To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplatin/paclitaxel chemotherapy in high risk patients with advanced ovarian cancer FIGO stage III using IMRT (Intensity modulat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Arians, Nathalie (VerfasserIn) , Kieser, Meinhard (VerfasserIn) , Benner, Laura (VerfasserIn) , Katayama, Sonja (VerfasserIn) , Herfarth, Klaus (VerfasserIn) , Schubert, Kai (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Sohn, Christof (VerfasserIn) , Lindel, Katja (VerfasserIn) , Debus, Jürgen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 October 2019
In: Radiation oncology
Year: 2019, Jahrgang: 14
ISSN:1748-717X
DOI:10.1186/s13014-019-1381-2
Online-Zugang:Verlag, Volltext: https://doi.org/10.1186/s13014-019-1381-2
Volltext
Verfasserangaben:Nathalie Arians, Meinhard Kieser, Laura Benner, Nathalie Rochet, Lars Schröder, Sonja Katayama, Klaus Herfarth, Kai Schubert, Andreas Schneeweiss, Christof Sohn, Katja Lindel and Jürgen Debus

MARC

LEADER 00000caa a2200000 c 4500
001 1683823354
003 DE-627
005 20210817112930.0
007 cr uuu---uuuuu
008 191129s2019 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13014-019-1381-2  |2 doi 
035 |a (DE-627)1683823354 
035 |a (DE-599)KXP1683823354 
035 |a (OCoLC)1264136468 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Arians, Nathalie  |d 1986-  |e VerfasserIn  |0 (DE-588)1035620782  |0 (DE-627)74879199X  |0 (DE-576)383388600  |4 aut 
245 1 0 |a Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III  |b final results of a prospective phase 2 study  |c Nathalie Arians, Meinhard Kieser, Laura Benner, Nathalie Rochet, Lars Schröder, Sonja Katayama, Klaus Herfarth, Kai Schubert, Andreas Schneeweiss, Christof Sohn, Katja Lindel and Jürgen Debus 
264 1 |c 21 October 2019 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.11.2019 
520 |a Background: To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplatin/paclitaxel chemotherapy in high risk patients with advanced ovarian cancer FIGO stage III using IMRT (Intensity modulated radiation therapy). Methods: The OVAR-IMRT-02 study is a multi-center single-arm phase-II-trial. Twenty patients with optimally debulked ovarian cancer stage FIGO III with complete remission after chemotherapy were treated with intensity modulated WART. A total dose of 30 Gy in 20 fractions was applied to the entire peritoneal cavity. Primary endpoint was treatment tolerability; secondary objectives were acute and chronic toxicities, quality of life, rates of therapy disruption/abortion, progression-free survival (PFS) and overall survival (OS). Results: All patients completed treatment and 10/20 patients (50%) reached the final study follow-up of 36 months. Late side effects consisted of °1-°2 lower limb edema (44.5%), with one patient (5.6%) showing °3 edema. Three patients (16.7%) showed elevated gamma-Glutamyltransferase. There were no severe late side effects regarding renal or hepatic function or any gastrointestinal toxicity greater than °2. During WART, mean global health status decreased by 18.1 points (95%-CI: 7.1–29.0), but completely normalized after 6 months. The same trend was observed for the function scale scores. Kaplan-Meier-estimated 1-, 2- and 3-year PFS was 74, 51 and 40%, respectively. 1-, 2- and 3-year OS was 89, 83 and 83%, respectively. Conclusions: Intensity modulated WART after aggressive surgery and carboplatin/paclitaxel chemotherapy is associated with an acceptable risk of acute and late toxicity and minor impact on long-term quality of life. Together with the promising results for PFS and OS, intensity modulated WART could offer a new therapeutic option for consolidation treatment of patients with advanced ovarian cancer. Trial registration: The study is registered with ClinicalTrials.gov (NCT01180504). Registered 12 August 2010 – retrospectively registered. 
700 1 |a Kieser, Meinhard  |d 1960-  |e VerfasserIn  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 aut 
700 1 |a Benner, Laura  |d 1990-  |e VerfasserIn  |0 (DE-588)1155943597  |0 (DE-627)1018499296  |0 (DE-576)501946616  |4 aut 
700 1 |a Katayama, Sonja  |e VerfasserIn  |0 (DE-588)1067255028  |0 (DE-627)818554177  |0 (DE-576)426512979  |4 aut 
700 1 |a Herfarth, Klaus  |e VerfasserIn  |0 (DE-588)1032757582  |0 (DE-627)739273116  |0 (DE-576)171352289  |4 aut 
700 1 |a Schubert, Kai  |d 1967-  |e VerfasserIn  |0 (DE-588)1083291157  |0 (DE-627)847939901  |0 (DE-576)455687765  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Sohn, Christof  |d 1961-  |e VerfasserIn  |0 (DE-588)131349287  |0 (DE-627)507642902  |0 (DE-576)298422255  |4 aut 
700 1 |a Lindel, Katja  |d 1972-  |e VerfasserIn  |0 (DE-588)121342689  |0 (DE-627)705399176  |0 (DE-576)292658044  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
773 0 8 |i Enthalten in  |t Radiation oncology  |d London : BioMed Central, 2006  |g 14(2019) Artikel-Nummer 179, 10 Seiten  |h Online-Ressource  |w (DE-627)508725739  |w (DE-600)2224965-5  |w (DE-576)260614815  |x 1748-717X  |7 nnas  |a Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III final results of a prospective phase 2 study 
773 1 8 |g volume:14  |g year:2019  |g extent:10  |a Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III final results of a prospective phase 2 study 
856 4 0 |u https://doi.org/10.1186/s13014-019-1381-2  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20191129 
993 |a Article 
994 |a 2019 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 12  |y j 
998 |g 121342689  |a Lindel, Katja  |m 121342689:Lindel, Katja  |d 50000  |e 50000PL121342689  |k 0/50000/  |p 11 
998 |g 131349287  |a Sohn, Christof  |m 131349287:Sohn, Christof  |d 910000  |d 910400  |e 910000PS131349287  |e 910400PS131349287  |k 0/910000/  |k 1/910000/910400/  |p 10 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 9 
998 |g 1083291157  |a Schubert, Kai  |m 1083291157:Schubert, Kai  |d 910000  |d 911400  |e 910000PS1083291157  |e 911400PS1083291157  |k 0/910000/  |k 1/910000/911400/  |p 8 
998 |g 1032757582  |a Herfarth, Klaus  |m 1032757582:Herfarth, Klaus  |d 910000  |d 911400  |e 910000PH1032757582  |e 911400PH1032757582  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 1067255028  |a Katayama, Sonja  |m 1067255028:Katayama, Sonja  |d 910000  |d 911400  |e 910000PK1067255028  |e 911400PK1067255028  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 1155943597  |a Benner, Laura  |m 1155943597:Benner, Laura  |d 910000  |d 999701  |e 910000PB1155943597  |e 999701PB1155943597  |k 0/910000/  |k 1/910000/999701/  |p 3 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 999701  |e 910000PK103276547X  |e 999701PK103276547X  |k 0/910000/  |k 1/910000/999701/  |p 2 
998 |g 1035620782  |a Arians, Nathalie  |m 1035620782:Arians, Nathalie  |d 910000  |d 911400  |e 910000PA1035620782  |e 911400PA1035620782  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1683823354  |e 3551416842 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1683823354"],"doi":["10.1186/s13014-019-1381-2"]},"note":["Gesehen am 29.11.2019"],"person":[{"role":"aut","display":"Arians, Nathalie","family":"Arians","given":"Nathalie"},{"family":"Kieser","given":"Meinhard","role":"aut","display":"Kieser, Meinhard"},{"family":"Benner","given":"Laura","display":"Benner, Laura","role":"aut"},{"family":"Katayama","given":"Sonja","role":"aut","display":"Katayama, Sonja"},{"given":"Klaus","family":"Herfarth","role":"aut","display":"Herfarth, Klaus"},{"display":"Schubert, Kai","role":"aut","given":"Kai","family":"Schubert"},{"family":"Schneeweiss","given":"Andreas","role":"aut","display":"Schneeweiss, Andreas"},{"role":"aut","display":"Sohn, Christof","given":"Christof","family":"Sohn"},{"family":"Lindel","given":"Katja","display":"Lindel, Katja","role":"aut"},{"role":"aut","display":"Debus, Jürgen","family":"Debus","given":"Jürgen"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"subtitle":"final results of a prospective phase 2 study","title_sort":"Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III","title":"Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III"}],"recId":"1683823354","relHost":[{"pubHistory":["1.2006 -"],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"BioMed Central","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisherPlace":"London"}],"recId":"508725739","title":[{"title":"Radiation oncology","title_sort":"Radiation oncology"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III final results of a prospective phase 2 studyRadiation oncology","id":{"zdb":["2224965-5"],"issn":["1748-717X"],"eki":["508725739"]},"part":{"extent":"10","text":"14(2019) Artikel-Nummer 179, 10 Seiten","year":"2019","volume":"14"},"note":["Gesehen am 06.09.10"]}],"name":{"displayForm":["Nathalie Arians, Meinhard Kieser, Laura Benner, Nathalie Rochet, Lars Schröder, Sonja Katayama, Klaus Herfarth, Kai Schubert, Andreas Schneeweiss, Christof Sohn, Katja Lindel and Jürgen Debus"]},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"21 October 2019"}],"physDesc":[{"extent":"10 S."}]} 
SRT |a ARIANSNATHADJUVANTIN2120